Olivia Newton-John Cancer Research Institute

Organization name
Olivia Newton-John Cancer Research Institute
Parent OrgUnit
City
Heidelberg, Victoria
Country
Australia


Results 741-755 of 755 (Search time: 0.009 seconds).

Publication YearTitleAuthor(s)
74127-Mar-2015Patients' perspectives of accessibility and digital delivery of factual content provided by official medical and surgical specialty society websites: a qualitative assessmentOw, Darren; Wetherell, David ; Papa, Nathan P; Bolton, Damien M ; Lawrentschuk, Nathan
74222-Mar-2015Optimal timing of oral fosfomycin administration for pre-prostate biopsy prophylaxis.Rhodes, Nathaniel J; Gardiner, Bradley J; Neely, Michael N; Grayson, M Lindsay ; Ellis, Andrew G ; Lawrentschuk, Nathan; Frauman, Albert G ; Maxwell, Kelly M; Zembower, Teresa R; Scheetz, Marc H
74310-Mar-2015Non-invasive assessment of the efficacy of new therapeutics for intestinal pathologies using serial endoscopic imaging of live miceErnst, Matthias ; Preaudet, Adele; Putoczki, Tracy
7445-Mar-2015Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.Wong, S Q; Fellowes, A; Doig, K; Ellul, J; Bosma, T J; Irwin, D; Vedururu, R; Tan, A Y-C; Weiss, Jonathan; Chan, K S; Lucas, M; Thomas, D M; Dobrovic, Alexander ; Parisot, J P; Fox, S B
7452-Feb-2015Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancer.Pereira, Lloyd; Mariadason, John M ; Hannan, Ross D; Dhillon, Amardeep S
7461-Feb-2015Targeting the androgen receptor in breast cancer.Chia, KeeMing; O'Brien, Megan; Brown, Myles; Lim, Elgene
7476-Jan-2015T cells recognizing a 11mer influenza peptide complexed to H-2D(b) show promiscuity for peptide length.Zanker, Damien; Quinn, Kylie; Waithman, Jason; Lata, Roleen; Murphy, Roger; La Gruta, Nicole Louise; Chen, Weisan
7489-Dec-2014Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.Deb, Siddhartha; Wong, S Q; Li, J ; Do, Hongdo; Weiss, J ; Byrne, D; Chakrabarti, A; Bosma, T; Fellowes, A; Dobrovic, Alexander ; Fox, S B
74924-Nov-2014Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization.Do, Hongdo; Dobrovic, Alexander 
75018-Jul-2014Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling.Robson, Neil C; Hidalgo, Laura; McAlpine, Tristan; Wei, Heng; Martínez, Víctor G; Entrena, Ana; Melen, Gustavo J; MacDonald, Andrew S; Phythian-Adams, Alexander; Sacedón, Rosa; Maraskovsky, Eugene; Cebon, Jonathan S ; Ramírez, Manuel; Vicente, Angeles; Varas, Alberto
7511-Jun-2014Evolving role of tumor antigens for future melanoma therapies.Andrews, Miles C; Woods, Katherine; Cebon, Jonathan S ; Behren, Andreas
75226-Feb-2014A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.Do, Hongdo; Wong, Nicholas C; Murone, Carmel ; John, Thomas ; Solomon, Benjamin J; Mitchell, Paul L R ; Dobrovic, Alexander 
75315-Apr-2011Biomarkers of 5-FU response in colon cancer.Mariadason, John M ; Tebbutt, Niall C 
7546-Feb-2007Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis.Damianovich, D; Adena, M; Tebbutt, Niall C 
75516-Nov-2004Tumor antigen processing and presentation depend critically on dendritic cell type and the mode of antigen delivery.Schnurr, Max; Chen, Qiyuan; Shin, Amanda; Chen, Weisan; Toy, Tracey; Jenderek, Corinna; Green, Simon; Miloradovic, Lena; Drane, Debbie; Davis, Ian D; Villadangos, Jose; Shortman, Ken; Maraskovsky, Eugene; Cebon, Jonathan S